Articles I ran into when researching cancer f-18 16 alpha-fluoroestradiol

Material I've come accross when looking into cancer f-18 16 alpha-fluoroestradiol.

Male Breast Cancer Clinical Trial: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy [Conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer; Interventions: vorinostat, laboratory biomarker analysis, biopsy, F-18 16 alpha-fluoroestradiol, positron emission tomography, anastrozole, letrozole, exemestane, gene]. ^[1]

PURPOSE: This phase II trial is studying how well F-18 16 alpha-fluoroestradiol imaging works in predicting response to first-line hormone therapy in women with hormone receptor-positive metastatic breast cancer. ^[2]

Breast Cancer Clinical Trial: F-18 16 Alpha-Fluoroestradiol Imaging in Predicting Response to First-Line Hormone Therapy in Women With Hormone Receptor-Positive Metastatic Breast Cancer [Conditions: Breast Cancer; Interventions: F-18 16]. ^[3]

References:

1. Male Breast Cancer Clinical Trial: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy [Conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer; Interventions: vorinostat, laboratory bio


2. F-18 16 Alpha-Fluoroestradiol Imaging in Predicting Response to First-Line Hormone Therapy in Women With Hormone Receptor-Positive Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov


3. Breast Cancer Clinical Trial: F-18 16 Alpha-Fluoroestradiol Imaging in Predicting Response to First-Line Hormone Therapy in Women With Hormone Receptor-Positive Metastatic Breast Cancer [Conditions: Breast Cancer; Interventions: F-18 16 alpha-fluoroestradi